Paysign Reports Record Third Quarter 2026 Revenue of $30.8 Million, Up 43%; Operating Margin More Than Triples to 23.8%

HENDERSON, Nev.–(BUSINESS WIRE)–Paysign, Inc. (NASDAQ: PAYS), a provider of patient affordability offerings, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced financial results for the third quarter 2026. Third Quarter 2026 Financial Highlights Revenues of $30.80 million in Q3’26, up 42.6% from Q3’25 Pharma revenue increased 109.8% to $16.62 million in Q3’26 versus Q3’25; added 62 net patient a

Please leave this field empty

Subscribe to Our Newsletter

We keep your data private and share your data only with third parties that make this service possible. See our Privacy Policy for more information.

Please check your Inbox or Spam folder now to confirm your subscription.